课题基金 / 基金详情

Development of clinical genome information systems for pharmacokinetics analysis

Development of clinical genome information systems for pharmacokinetics analysis
用于药代动力学分析的临床基因组信息系统的开发
批准号:
16200038
负责人:
OYAMA Hiroshi
金额:
$30.2万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

OYAMA Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We developed a clinical genome information grid search system that can extract comprehensive drug-related information from two or more life-science databases (DBs) using OGSA-WebDB technology, which is a database grid technology. The retrieval DBs are TOXINET (an adverse-drug-reaction document information DB), PharmGKB (a drug-related gene DB), Entrez Protein (a protein information DB), LSBM (a gene-expression organ DB), KEGG (a pathway-information DB), and JSNP (a single nucleotide polymorphism (SNP) information DB). The system can extract references to the newest drug responsibility genes and organs, metabolic pathway data, and protein information relevant to adverse reactions to anti-cancer or other drugs, and researchers can estimate the causal relationships between a drug responsibility gene and an adverse drug reaction. Using this, we verified the adverse drug reaction between irinotecan hydrochloride and cisplatin in combination therapy. The common pathways are the ABC transporters that are involved in the metabolism of xenobiotics by cytochrome P450, and starch and sucrose metabolism and 56 SNPs were extracted as relevant polymorphisms. A pharmacokinetics analysis algorithm for irinotecan hydrochloride was created based on clinical case data. We developed a clinical genome pharmacokinetics simulation system in which the chronological concentration change of CPT-11, SN-38, and SN-38G in each compartment can be visualized as a graph after selecting the genotype (wild-type, heterozygote, homozygote), body height, weight, and actual drug dose. It can also simulate the UGT1A1 allele type patterns of ^*28 and ^*6. We propose the system specifications for a clinical genome information-management system that includes clinical genome data, patient case data, and pharmacokinetics data. The prototype system was developed using Apache2.2.0, PHP5.1.1, MySQL5.0.18, and Java programming language on a UNIX server.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1196/annals.1377.020
发表时间: 2006-01-01
期刊: INTEGRATED MOLECULAR MEDICINE FOR NEURONAL AND NEOPLASTIC DISORDERS
影响因子: --
作者: [Hasegawa, Yoshinori, Ando, Yuichi, Shimokata, Kaoru]
通讯作者: Shimokata, Kaoru
抗悪性腫瘍薬.医系薬理学 改訂2版(遠藤仁,橋本敬太郎,後藤勝年,金井好克編)
抗肿瘤药物,修订第2版(远藤仁、桥本启太郎、后藤胜俊、金井佳胜主编)
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: [安藤雄一, 佐々木康綱]
通讯作者: 佐々木康綱
抗がん剤のファーマコジェノミクス
抗癌药物的药物基因组学
DOI: --
发表时间: 2004
期刊: 血液・腫瘍科 48・2
影响因子: --
作者: [Yuichi Ando, 安藤雄一]
通讯作者: 安藤雄一
グルクロン酸転移酵素UGT1A1の遺伝子多型に基づく塩酸イリノテカンの個別化治療.
基于葡萄糖醛酸转移酶 UGT1A1 基因多态性的盐酸伊立替康个体化治疗
DOI: --
发表时间: 2005
期刊: 最新医学 60(9)
影响因子: --
作者: [Takemoto M, et al., 安藤雄一]
通讯作者: 安藤雄一
18
    Understanding the promotion factors of the adaptive expertise
    • 批准号:
      23650065
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      OYAMA Hiroshi
    • 依托单位:
    Research on Japanese style of social enterprise(social firm)
    • 批准号:
      22530627
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.91万
    • 财政年份:
      2010
    • 负责人:
      OYAMA Hiroshi
    • 依托单位:
    海外基金